hero banner

hero banner mobile

Click on image to open expanded view Item No. 52674

Laverdia-CA1 (Verdinexor) Tablets for Dogs Rx

Availability:
  • In Stock
AutoShip & Save 20%
Save 14% on your 1st AutoShip order and 5% on all future AutoShip orders Learn more
Strength:
Count:

Sorry, there is a manufacturer back order on this item.

Product Description
LAVERDIA-CA1 is a conditionally approved cancer drug used to treat lymphoma in dogs. The active ingredient in LAVERDIA-CA1 is verdinexor, a substance that works by preventing tumor suppressing proteins from leaving the nucleus of cells, resulting in disruption of cancer cell survival and eventual cancer cell death.
Who is Laverdia-CA1 (Verdinexor) Tablets for Dogs for?
Dogs
Why use Laverdia-CA1 (Verdinexor) Tablets for Dogs?
Helps treat lymphoma in dogs. Easy to administer tablets.
How does Laverdia-CA1 (Verdinexor) Tablets for Dogs work?
The active ingredient in LAVERDIA-CA1 is verdinexor, a substance that works by preventing tumor suppressing proteins from leaving the nucleus of cells, resulting in disruption of cancer cell survival and eventual cancer cell death.
Manufacturer:
Dechra
Active Ingredients(s):
Verdinexor
How is Laverdia-CA1 (Verdinexor) Tablets for Dogs sold?
Sold in strengths of 2.5 mg, 10 mg and 50 mg tablets. All strengths available in 50 tablet bottles, in addition the 50 mg strength is also available in a 16 tablet bottle.
What are the side effects of Laverdia-CA1 (Verdinexor) Tablets for Dogs?
The most commonly reported adverse reactions in dogs include anorexia, weight loss, vomiting, diarrhea, lethargy, polyuria, polydipsia, elevated liver enzymes and thrombocytopenia.
What special precautions are there?
For use in dogs only. Laverdia™-CA1(verdinexor) is conditionally approved for the treatment of lymphoma in dogs. NOT FOR USE IN HUMANS. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. CHILDREN SHOULD NOT COME INTO CONTACT WITH Laverdia™-CA1. Pregnant women, women who may become pregnant, nursing women and children should not handle or administer Laverdia™-CA1 or come into contact with the feces, urine, saliva, or vomit of treated dogs for 3 days following treatment. Laverdia™-CA1 can affect male fertility based on animal studies and studies in humans. Wear protective disposable chemotherapy resistant gloves when handling Laverdia™-CA1 to avoid direct exposure to moistened, broken or crushed tablets or biological waste from the treated dog (feces, urine, saliva, or vomit). Do not use in dogs that are pregnant, lactating or intended for breeding. Laverdia-CA1 is a possible teratogen and can affect female and male fertility. Dogs should be frequently monitored for hematologic and serum chemistry abnormalities.
What to do if overdose?
Contact your nearest emergency animal hospital.
How can I store Laverdia-CA1 (Verdinexor) Tablets for Dogs?
Store the bottles at controlled room temperature 20° to 25°C (68° – 77°F).
Overview
Use as directed by your Veterinarian.
Main Ingredients
Verdinexor